Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 3

Results: 29

In this issue: Volume 115, Issue 3, March 2024.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 695, doi. 10.1111/cas.16115
Publication type:
Article
Progressive, multi‐organ, and multi‐layered nature of cancer cachexia.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 715, doi. 10.1111/cas.16078
By:
- Nakamura, Yuki;
- Saldajeno, Don Pietro;
- Kawaguchi, Kosuke;
- Kawaoka, Shinpei
Publication type:
Article
Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 871, doi. 10.1111/cas.16077
By:
- Katayama, Haruyoshi;
- Fujimura, Atsushi;
- Huang, Rongsheng;
- Otani, Yusuke;
- Itano, Takuto;
- Fujiwara, Tomohiro;
- Kunisada, Toshiyuki;
- Nakata, Eiji;
- Ozaki, Toshifumi
Publication type:
Article
DEAD‐box helicase 1 inhibited CD8+ T cell antitumor activity by inducing PD‐L1 expression in hepatocellular carcinoma.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 763, doi. 10.1111/cas.16076
By:
- Liu, Junhao;
- Yang, Ti;
- Luo, Yurong;
- Ma, Zengxin;
- Yu, Zhitao;
- Zhang, Lei;
- Liu, Gai;
- Wen, Jianfan;
- Lu, Guankun;
- Zhang, Guowei;
- Zhao, Yujun;
- Luo, Wang;
- Li, Yanan;
- Yang, Nengjia;
- Zhou, Jiawei;
- Lu, Yuhui;
- Chen, Siliang;
- Zeng, Xiancheng
Publication type:
Article
Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT‐CTTN level.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 836, doi. 10.1111/cas.16075
By:
- Bao, Lili;
- Zhong, Ming;
- Zhang, Zixiang;
- Yu, Xiangqing;
- You, Bo;
- You, Yiwen;
- Gu, Miao;
- Zhang, Qicheng;
- Chen, Wenhui;
- Lei, Wei;
- Hu, Songqun
Publication type:
Article
Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 989, doi. 10.1111/cas.16074
By:
- Kang, Huiram;
- Hwang, Sohyun;
- Kang, Haeyoun;
- Jo, Areum;
- Lee, Ji Min;
- Choi, Jung Kyoon;
- An, Hee Jung;
- Lee, Hae‐Ock
Publication type:
Article
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 791, doi. 10.1111/cas.16073
By:
- Hirose, Shiho;
- Mashima, Tetsuo;
- Yuan, Xunmei;
- Yamashita, Makiko;
- Kitano, Shigehisa;
- Torii, Shinichi;
- Migita, Toshiro;
- Seimiya, Hiroyuki
Publication type:
Article
Why Y matters? The implication of loss of Y chromosome in blood and cancer.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 706, doi. 10.1111/cas.16072
By:
- Wang, Ying;
- Sano, Soichi
Publication type:
Article
Anti‐angiogenesis in colorectal cancer therapy.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 734, doi. 10.1111/cas.16063
By:
- Yang, Zhenni;
- Zhang, Xuqian;
- Bai, Xiaozhe;
- Xi, Xiaonan;
- Liu, Wentian;
- Zhong, Weilong
Publication type:
Article
Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 859, doi. 10.1111/cas.16070
By:
- Fukuoka, Makoto;
- Kodama, Takahiro;
- Murai, Kazuhiro;
- Hikita, Hayato;
- Sometani, Emi;
- Sung, Jihyun;
- Shimoda, Akiyoshi;
- Shigeno, Satoshi;
- Motooka, Daisuke;
- Nishio, Akira;
- Furuta, Kunimaro;
- Tatsumi, Tomohide;
- Yusa, Kosuke;
- Takehara, Tetsuo
Publication type:
Article
IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 777, doi. 10.1111/cas.16068
By:
- Zhou, Menghua;
- Yu, Hongjun;
- Bai, Miaoyu;
- Lu, Shounan;
- Wang, Chaoqun;
- Ke, Shanjia;
- Huang, Jingjing;
- Li, Zihao;
- Xu, Yanan;
- Yin, Bing;
- Li, Xinglong;
- Feng, Zhigang;
- Fu, Yao;
- Jiang, Hongchi;
- Ma, Yong
Publication type:
Article
Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 974, doi. 10.1111/cas.16067
By:
- Dai, Ting;
- Qiu, Shengkui;
- Gao, Xuesong;
- Zhao, Chengjin;
- Ge, Zhenming;
- Yang, Yanmei;
- Tang, Chong;
- Feng, Shichun
Publication type:
Article
Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 820, doi. 10.1111/cas.16059
By:
- Ma, Zhijian;
- Gu, Qianlin;
- Dai, Yiwei;
- Wang, Qiaoyan;
- Shi, Wengui;
- Jiao, Zuoyi
Publication type:
Article
Ex vivo expansion of human hematopoietic stem cells and clinical applications.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 698, doi. 10.1111/cas.16066
By:
- Sakurai, Masatoshi;
- Ishitsuka, Kantaro;
- Becker, Hans Jiro;
- Yamazaki, Satoshi
Publication type:
Article
Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 963, doi. 10.1111/cas.16069
By:
- Frett, Brendan;
- Stephens, Kimberly E.;
- Koss, Brian;
- Melnyk, Stepan;
- Farrar, Jason;
- Saha, Debasmita;
- Roy Choudhury, Samrat
Publication type:
Article
L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 937, doi. 10.1111/cas.16062
By:
- Rii, Junryo;
- Sakamoto, Shinichi;
- Mizokami, Atsushi;
- Xu, Minhui;
- Fujimoto, Ayumi;
- Saito, Shinpei;
- Koike, Hidekazu;
- Tamura, Takaaki;
- Arai, Takayuki;
- Yamada, Yasutaka;
- Goto, Yusuke;
- Sazuka, Tomokazu;
- Imamura, Yusuke;
- Suzuki, Kazuhiro;
- Kanai, Yoshikatsu;
- Anzai, Naohiko;
- Ichikawa, Tomohiko
Publication type:
Article
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 752, doi. 10.1111/cas.16061
By:
- Hosonuma, Masahiro;
- Hirasawa, Yuya;
- Kuramasu, Atsuo;
- Murayama, Masakazu;
- Narikawa, Yoichiro;
- Toyoda, Hitoshi;
- Baba, Yuta;
- Isobe, Junya;
- Funayama, Eiji;
- Tajima, Kohei;
- Shida, Midori;
- Hamada, Kazuyuki;
- Tsurui, Toshiaki;
- Ariizumi, Hirotsugu;
- Ishiguro, Tomoyuki;
- Suzuki, Risako;
- Ohkuma, Ryotaro;
- Kubota, Yutaro;
- Horiike, Atsushi;
- Sambe, Takehiko
Publication type:
Article
Immature stroma and high infiltration of CD15+ cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 1001, doi. 10.1111/cas.16060
By:
- Yamada, Yutaka;
- Yamamoto, Takeo;
- Tsutsumi, Chikanori;
- Matsumoto, Takashi;
- Noguchi, Shoko;
- Shimada, Yuki;
- Nakata, Kohei;
- Ohuchida, Kenoki;
- Nakamura, Masafumi;
- Oda, Yoshinao
Publication type:
Article
Patient survey on cancer genomic medicine in Japan under the national health insurance system.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 954, doi. 10.1111/cas.16065
By:
- Kage, Hidenori;
- Akiyama, Nana;
- Chang, Hyangri;
- Shinozaki‐Ushiku, Aya;
- Ka, Mirei;
- Kawata, Junichi;
- Muto, Manabu;
- Okuma, Yusuke;
- Okita, Natsuko;
- Tsuchihara, Katsuya;
- Kikuchi, Junko;
- Shirota, Hidekazu;
- Hayashi, Hideyuki;
- Kokuryo, Toshio;
- Yachida, Shinichi;
- Hirasawa, Akira;
- Kubo, Makoto;
- Kenmotsu, Hirotsugu;
- Tanabe, Masahiko;
- Ushiku, Tetsuo
Publication type:
Article
Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 894, doi. 10.1111/cas.16058
By:
- Nishida, Toshirou;
- Naito, Yoichi;
- Takahashi, Tsuyoshi;
- Saito, Takuro;
- Hisamori, Shigeo;
- Manaka, Dai;
- Ogawa, Katsuhiro;
- Hirota, Seiichi;
- Ichikawa, Hitoshi
Publication type:
Article
Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 905, doi. 10.1111/cas.16057
By:
- Sun, Mengyao;
- Gu, Yun;
- Fang, Hanji;
- Shao, Fei;
- Lin, Chao;
- Zhang, Heng;
- Li, He;
- He, Hongyong;
- Li, Ruochen;
- Wang, Jieti;
- Liu, Hao;
- Xu, Jiejie
Publication type:
Article
Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase‐positive non‐small‐cell lung cancer.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 926, doi. 10.1111/cas.16056
By:
- Shimomura, Yuki;
- Sawa, Kenji;
- Imai, Takumi;
- Ihara, Yasutaka;
- Yoshida, Hisako;
- Shintani, Ayumi
Publication type:
Article
Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 916, doi. 10.1111/cas.16055
By:
- Yagi, Asami;
- Nakagawa, Satoshi;
- Ueda, Yutaka;
- Oka, Emiko;
- Ikeda, Sayaka;
- Kakuda, Mamoru;
- Kobayashi, Eiji;
- Ito, Yuri;
- Katayama, Kayoko;
- Hirai, Kei;
- Nakayama, Tomio;
- Kimura, Tadashi
Publication type:
Article
Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 847, doi. 10.1111/cas.16051
By:
- Kato, Yutaka;
- Fukazawa, Takahiro;
- Tanimoto, Keiji;
- Kanawa, Masami;
- Kojima, Masato;
- Saeki, Isamu;
- Kurihara, Sho;
- Touge, Ryo;
- Hirohashi, Nobuyuki;
- Okada, Satoshi;
- Hiyama, Eiso
Publication type:
Article
LINC00629, a HOXB4‐downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 804, doi. 10.1111/cas.16049
By:
- Liu, Jia;
- Zhu, Yuan;
- Wang, Huan;
- Han, Chuanchun;
- Wang, Yongpeng;
- Tang, Ranran
Publication type:
Article
RNA methylation in inflammatory bowel disease.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 723, doi. 10.1111/cas.16048
By:
- Ozato, Yuki;
- Hara, Tomoaki;
- Meng, Sikun;
- Sato, Hiromichi;
- Tatekawa, Shotaro;
- Uemura, Mamoru;
- Yabumoto, Takeshi;
- Uchida, Shizuka;
- Ogawa, Kazuhiko;
- Doki, Yuichiro;
- Eguchi, Hidetoshi;
- Ishii, Hideshi
Publication type:
Article
Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 1014, doi. 10.1111/cas.16039
By:
- Bando, Hideaki;
- Yamaguchi, Kyoko;
- Mitani, Seiichiro;
- Sawada, Kentaro;
- Mishima, Saori;
- Komine, Keigo;
- Okugawa, Yoshinaga;
- Hosoda, Waki;
- Ebi, Hiromichi
Publication type:
Article
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 883, doi. 10.1111/cas.15977
By:
- Ravegnini, Gloria;
- Gorini, Francesca;
- Coada, Camelia Alexandra;
- De Leo, Antonio;
- de Biase, Dario;
- Di Costanzo, Stella;
- De Crescenzo, Eugenia;
- Coschina, Emma;
- Monesmith, Sarah;
- Bernante, Paolo;
- Garelli, Silvia;
- Balsamo, Francesca;
- Hrelia, Patrizia;
- De Iaco, Pierandrea;
- Angelini, Sabrina;
- Perrone, Anna Myriam
Publication type:
Article
Issue Information.
Published in:
Cancer Science, 2024, v. 115, n. 3, p. 691, doi. 10.1111/cas.15859
Publication type:
Article

Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 3

In this issue: Volume 115, Issue 3, March 2024.

Progressive, multi‐organ, and multi‐layered nature of cancer cachexia.

Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors.

DEAD‐box helicase 1 inhibited CD8<sup>+</sup> T cell antitumor activity by inducing PD‐L1 expression in hepatocellular carcinoma.

Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT‐CTTN level.

Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma.

Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8<sup>+</sup> T cell infiltration in melanoma.

Why Y matters? The implication of loss of Y chromosome in blood and cancer.

Anti‐angiogenesis in colorectal cancer therapy.

Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells.

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.

Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis.

Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.

Ex vivo expansion of human hematopoietic stem cells and clinical applications.

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia.

L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Immature stroma and high infiltration of CD15<sup>+</sup> cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer.

Patient survey on cancer genomic medicine in Japan under the national health insurance system.

Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors.

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer.

Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase‐positive non‐small‐cell lung cancer.

Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan.

Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.

LINC00629, a HOXB4‐downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc.

RNA methylation in inflammatory bowel disease.

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.

Issue Information.